Classification of lipoproteins and lipoprotein disorders. [PDF]
openaire +2 more sources
Unveiling lipoprotein subfractions signature in high-FNPO PCOS: implications for PCOM diagnosis and risk assessment using advanced machine learning models. [PDF]
Yan X+10 more
europepmc +1 more source
Unraveling the Dyslipidemic Landscape in Moyamoya Disease: OxLDL as a Key Biomarker. [PDF]
Zeng C+16 more
europepmc +1 more source
Treatment of Homozygous Familial Hypercholesterolemia. [PDF]
Cegla J+4 more
europepmc +1 more source
Lipoprotein (a) levels and clinical decision-making: data from a Mexican cohort at a tertiary medical institution. [PDF]
Cruz-Bautista I+16 more
europepmc +1 more source
Combined association of lipoprotein(a) and European Society of Cardiology Systematic COronary Risk Evaluation 2 (SCORE2) with 10-year major adverse cardiovascular events: evidence from a single tertiary hospital including 9979 patients. [PDF]
Kim K, Kim M, Han J, Jun TJ, Kim YH.
europepmc +1 more source
The metabolic syndrome-insulin resistance index: a tool for identifying dyslipidemia across varied glucose metabolic score in patients with cardiovascular disease. [PDF]
Yu L+10 more
europepmc +1 more source
The value of triglyceride glucose-body mass index, fasting blood glucose to HDL-C ratio, and platelet to HDL-C ratio in predicting abdominal aortic calcification in maintenance hemodialysis patients. [PDF]
Chen S+6 more
europepmc +1 more source